Compare Merck & Co., Inc. (MRK) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs First Trust Cloud Computing ETF — how do they compare? Merck & Co., Inc. trades at $148.16 (market cap $363.98B), while First Trust Cloud Computing ETF trades at $158.14. The key difference: Merck & Co., Inc. pays a 2.3% dividend while First Trust Cloud Computing ETF pays none. Which is the better fit depends on your goals.
| MRK | SKYY | |
|---|---|---|
Market Cap | $363.98B | — |
Sector | Health | — |
52-Week High | $156.43 | $168.91 |
52-Week Low | $77.60 | $104.16 |
Enterprise Value | $410.75B | — |
Dividend Yield | 2.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MRK trades at $148.49, down 1.23% on the day, with a bullish technical signal from moving averages and support near $147. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.22. Revenue reached $65.01B in 2025, and the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline.
Outlook remains positive with a consensus price target of $157, offering ~6% upside. Risks include high P/E of 118.77 and competitive pressures in pharma. Institutional buying and a 67.57% buy rating from analysts support a constructive view, though net income margin of 4.77% warrants monitoring.
SKYY, the First Trust Cloud Computing ETF, trades at $159.62, down 1.2% today, with a neutral technical signal. It offers diversified exposure to cloud infrastructure and software, benefiting from AI adoption and digital transformation trends. Recent news highlights strong infrastructure spending and AI demand driving cloud computing growth, positioning SKYY for potential long-term gains.
The outlook for SKYY is positive due to secular trends in cloud migration and AI, though risks include market volatility and sector concentration. Analyst sentiment is cautiously optimistic, with institutional interest supporting the ETF's role in technology sector allocations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
